Back to Search
DANIEL STOVER, MD
MD
Pediatrics Physician
NPI: 1699399436IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
OTHER
Class of 2020
Research & Publications (20)
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.
PMID 18463792·Invest New Drugs·2008
3-trial
A delicate balance: TGF-beta and the tumor microenvironment.
PMID 17486574·J Cell Biochem·2007
6-review
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.
PMID 19096313·J Thorac Oncol·2009
3-trial
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
PMID 19451693·J Clin Invest·2009
8-other
Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment.
PMID 19067746·Eur J Haematol·2009
8-other
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
PMID 19417213·Blood·2009
7-preclinical
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.
PMID 19086032·J Cell Physiol·2009
7-preclinical
Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
PMID 19016584·J Bone Miner Res·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 225 E CHICAGO AVE
CHICAGO, IL 60611 - Phone
- (312) 227-2000
Quick Facts
- NPI
- 1699399436
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile